Back to
Empowered Funds, LLC
IBRX
3 quarters
Position history for
Empowered Funds, LLC's holdings in ImmunityBio, Inc.
Yes. Empowered Funds holds 13,205 shares of IBRX (ImmunityBio), worth $115,610, as of its Q2 2026 13F filing. It increased the position by 1,516 shares (+13.0%) from Q1 2026. Empowered Funds has held IBRX since Q4 2025, across 3 quarterly 13F filings.
Current Value
$115,610
Current Shares
13,205
Total Value Change
+$87,959
Total Shares Change
-760
Quarter-by-Quarter History